| Epidemiology and prognosis of breast cancer in young women HA Assi, KE Khoury, H Dbouk, LE Khalil, TH Mouhieddine, NS El Saghir Journal of thoracic disease 5 (Suppl 1), S2, 2013 | 476 | 2013 |
| Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020 | 194 | 2020 |
| Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma O Van Oekelen, CR Gleason, S Agte, K Srivastava, KF Beach, A Aleman, ... Cancer Cell 39 (8), 1028-1030, 2021 | 180 | 2021 |
| A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward B Wang, O Van Oekelen, TH Mouhieddine, DM Del Valle, J Richter, ... Journal of hematology & oncology 13, 1-12, 2020 | 131 | 2020 |
| Assessing the Lebanese population for their knowledge, attitudes and practices of antibiotic usage TH Mouhieddine, Z Olleik, MM Itani, S Kawtharani, H Nassar, R Hassoun, ... Journal of infection and public health 8 (1), 20-31, 2015 | 119 | 2015 |
| Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression M Bustoros, R Sklavenitis-Pistofidis, J Park, R Redd, B Zhitomirsky, ... Journal of Clinical Oncology 38 (21), 2380, 2020 | 110 | 2020 |
| MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer WY Chen, SY Liu, YS Chang, JJ Yin, H Yeh, TH Mouhieddine, ... Oncotarget, 2014 | 97 | 2014 |
| Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant TH Mouhieddine, AS Sperling, R Redd, J Park, M Leventhal, CJ Gibson, ... Nature communications 11 (1), 2996, 2020 | 88 | 2020 |
| Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression Y Kawano, O Zavidij, J Park, M Moschetta, K Kokubun, TH Mouhieddine, ... The Journal of Clinical Investigation 128 (6), 2487-2499, 2018 | 77 | 2018 |
| Monoclonal gammopathy of undetermined significance TH Mouhieddine, LD Weeks, IM Ghobrial Blood, The Journal of the American Society of Hematology 133 (23), 2484-2494, 2019 | 76 | 2019 |
| Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects TH Mouhieddine, FH Kobeissy, M Itani, A Nokkari, KKW Wang Neural regeneration research 9 (9), 901, 2014 | 54 | 2014 |
| The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma HF Bahmad, TH Mouhieddine, RM Chalhoub, S Assi, T Araji, F Chamaa, ... Oncotarget 9 (71), 33549, 2018 | 53 | 2018 |
| Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors S Abou Alaiwi, AH Nassar, W Xie, Z Bakouny, JE Berchuck, DA Braun, ... Cancer immunology research 8 (8), 1075-1084, 2020 | 52 | 2020 |
| Metformin and ara-a effectively suppress brain cancer by targeting cancer stem/progenitor cells TH Mouhieddine, A Nokkari, MM Itani, F Chamaa, H Bahmad, A Monzer, ... Frontiers in neuroscience 9, 442, 2015 | 47 | 2015 |
| Risk factors for multiple sclerosis and associations with anti-EBV antibody titers TH Mouhieddine, H Darwish, L Fawaz, B Yamout, H Tamim, SJ Khoury Clinical Immunology 158 (1), 59-66, 2015 | 47 | 2015 |
| Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells R El-Merahbi, YN Liu, A Eid, G Daoud, L Hosry, A Monzer, ... PLoS One 9 (11), e112453, 2014 | 41 | 2014 |
| Established and novel prognostic biomarkers in multiple myeloma M Bustoros, TH Mouhieddine, A Detappe, IM Ghobrial American Society of Clinical Oncology Educational Book 37, 548-560, 2017 | 39 | 2017 |
| Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation AS Nam, N Dusaj, F Izzo, R Murali, RM Myers, TH Mouhieddine, J Sotelo, ... Nature genetics 54 (10), 1514-1526, 2022 | 37 | 2022 |
| CDKN2A Alterations and Response to Immunotherapy in Solid Tumors E Adib, AH Nassar, EW Akl, S Abou Alaiwi, PV Nuzzo, TH Mouhieddine, ... Clinical Cancer Research 27 (14), 4025-4035, 2021 | 34 | 2021 |
| Phase II trial of combination of elotuzumab, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma C Liu, IM Ghobrial, M Bustoros, K Reyes, K Hornburg, AZ Badros, ... Blood 132 (Supplement 1), 154-154, 2018 | 29 | 2018 |
Muhieddine M ItaniPost Doctoral Research Fellow at Massachusetts General Hospital在 mgh.harvard.edu 的电子邮件经过验证
